Clinical Trial Update: Vaccine Therapy in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a vaccine therapy in patients with stage II/III multiple myeloma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage II Multiple Myeloma, Stage III Multiple Myeloma | Phase 2 | Status: COMPLETED